Wave Life Sciences (WVE) Capital Expenditures (2014 - 2026)
Wave Life Sciences (WVE) posted Capital Expenditures of $438000.0 for Q1 2026, up 43900.0% on a QoQ basis from -$1000.0 in Q4 2025, and up 165.45% year-over-year from $165000.0 in Q1 2025.
Wave Life Sciences (WVE) Capital Expenditures (2014 - 2026) Analysis & Trends
Wave Life Sciences' Capital Expenditures history runs 13 years deep, the most recent figure standing at $438000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 165.45% year-over-year to $438000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $991000.0 (up 44.46% YoY) and the FY2025 annual result came in at $718000.0, down 23.45% from the prior year.
- Capital Expenditures was $438000.0 for Q1 2026 at Wave Life Sciences, up from -$1000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $492000.0 in Q2 2022 and bottomed at -$1000.0 in Q4 2025.
- A 5-year average of $268823.5 and a median of $248000.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 1260.0% — and 2025, when it plunged 101.16%.
- Wave Life Sciences' Capital Expenditures stood at $204000.0 in 2022, then soared by 74.51% to $356000.0 in 2023, then slumped by 75.84% to $86000.0 in 2024, then plunged by 101.16% to -$1000.0 in 2025, then jumped by 43900.0% to $438000.0 in 2026.
- Business Quant data shows WVE's Capital Expenditures at $438000.0 in Q1 2026, -$1000.0 in Q4 2025, and $248000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 438,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 438,000.00 |
| Mar 31, 2026 | 438,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Jun 30, 2025 | 306,000.00 |
| Jun 30, 2025 | 306,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 417,000.00 |
| Mar 31, 2024 | 417,000.00 |
| Dec 31, 2023 | 356,000.00 |
| Dec 31, 2023 | 356,000.00 |